"Natural Killer T-Cells" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A specialized subset of T-LYMPHOCYTES that exhibit features of INNATE IMMUNITY similar to that of NATURAL KILLER CELLS. They are reactive to glycolipids presented in the context of the major histocompatibility complex (MHC) class I-like molecule, CD1D ANTIGEN.
| Descriptor ID |
D055611
|
| MeSH Number(s) |
A11.118.637.555.567.569.290 A15.145.229.637.555.567.569.360 A15.382.490.555.567.569.470
|
| Concept/Terms |
Natural Killer T-Cells- Natural Killer T-Cells
- Killer T-Cell, Natural
- Killer T-Cells, Natural
- Natural Killer T Cells
- T-Cell, Natural Killer
- T-Cells, Natural Killer
- NKT Cells
- Natural Killer T-Cell
- Natural Killer T Cell
- NKT Cell
|
Below are MeSH descriptors whose meaning is more general than "Natural Killer T-Cells".
Below are MeSH descriptors whose meaning is more specific than "Natural Killer T-Cells".
This graph shows the total number of publications written about "Natural Killer T-Cells" by people in this website by year, and whether "Natural Killer T-Cells" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2010 | 0 | 1 | 1 |
| 2011 | 2 | 0 | 2 |
| 2015 | 1 | 0 | 1 |
| 2016 | 2 | 2 | 4 |
| 2017 | 9 | 3 | 12 |
| 2018 | 13 | 1 | 14 |
| 2019 | 4 | 2 | 6 |
| 2020 | 4 | 0 | 4 |
| 2021 | 2 | 1 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Natural Killer T-Cells" by people in Profiles.
-
Potent Neutralizing Antibodies Elicited by RBD-Fc-Based COVID-19 Vaccine Candidate Adjuvanted by the Th2-Skewing iNKT Cell Agonist. J Med Chem. 2021 08 12; 64(15):11554-11569.
-
Optimizing Flow Cytometric Analysis of Immune Cells in Samples Requiring Cryopreservation from Tumor-Bearing Mice. J Immunol. 2021 07 15; 207(2):720-734.
-
Natural killer cells and unconventional T cells in COVID-19. Curr Opin Virol. 2021 08; 49:176-182.
-
Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumonia. Immunity. 2021 07 13; 54(7):1578-1593.e5.
-
Analysis of the Long-Term Impact on Cellular Immunity in COVID-19-Recovered Individuals Reveals a Profound NKT Cell Impairment. mBio. 2021 04 27; 12(2).
-
Can we define CD3+CD56+ cells as NKT cells with impunity? Clin Immunol. 2021 05; 226:108708.
-
Early Phases of COVID-19 Are Characterized by a Reduction in Lymphocyte Populations and the Presence of Atypical Monocytes. Front Immunol. 2020; 11:560330.
-
Phenotypical and functional alteration of unconventional T cells in severe COVID-19 patients. J Exp Med. 2020 12 07; 217(12).
-
The renin-angiotensin-aldosterone system inhibitors in COVID-19: from acidosis to ventilation and immunity. Swiss Med Wkly. 2020 11 30; 150:w20444.
-
Major reduction of NKT cells in patients with severe COVID-19 pneumonia. Clin Immunol. 2021 01; 222:108630.